Search results
Lomustine (CCNU), an oral alkylating agent, was evaluated in 43 dogs with relapsed lymphoma or lymphoma that did not go into complete remission (CR). The dogs were treated with 90–100 mg/m 2 PO q 3 weeks and showed a durable response with 3 CR, 8 PR (partial remission) for a median of 86 days.
Firstly, to discover suitable and measurable biomarker tests for canine lymphoma. Secondly, to refine a testing system using mathematical models capable of quantifying and monitoring disease progress in dogs diagnosed with lymphoma. Two biomarkers were discovered using mass spectrometry.
Lymphoma in dogs is often diagnosed through a combination of findings on physical examination and cytologic evaluation of fine-needle aspirates of enlarged lymph nodes. Most dogs with lymphoma respond positively to systemic chemotherapy, with improved quality of life and overall survival time.
This retrospective case-control study compares hematological parameters and complete blood count ratios between a population of 114 dogs affected by Multicentric Large B-Cell Lymphoma (LBCL) and 60 healthy dogs.
For most dogs with multicentric lymphoma, diagnostic evaluation should include a complete blood count (CBC), serum chemistry panel, urinalysis, thoracic radiographs, and abdominal ultrasound. Thoracic radiographic changes consistent with lymphoma may include diffuse or localized pulmonary
12 sty 2024 · This article discusses the three most commonly employed diagnostic tests when a definitive cytologic diagnosis of canine lymphoma cannot be reached, 1) histopathologic evaluation, 2) immunophenotyping, and 3) PCR for antigen receptor rearrangement (PARR).
Canine lymphoma is often relatively easy to diagnose by taking a small sample of tissue or cells from the affected organ system. In dogs with multicentric lymphoma, a needle biopsy of enlarged lymph nodes usually provides enough cells to confirm the diagnosis.
